Author | Robert M. Rifkin, MD | OncLive

Author | Robert M. Rifkin, MD


Dr. Rifkin on Split Dosing of Daratumumab in Myeloma

January 04, 2019


Robert M. Rifkin, MD, attending physician, Rocky Mountain Cancer Centers, research lead, Multiple Myeloma, The US Oncology Network, discusses a trial looking at split dosing of daratumumab in myeloma.

A Perfect Storm Brews for Biosimilar Marketing

October 03, 2018


Pressure to reduce costs associated with biologics is one of the forces driving the rapid expansion of biosimilars, which are biological drugs that are very similar to already approved reference biologics in terms of potency, safety, and efficacy.